Erina Vlashi, Ph.D.

Affiliations: 
2007 Chemistry Purdue University, West Lafayette, IN, United States 
Area:
ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseases
Google:
"Erina Vlashi"
Mean distance: 12.9
 
SNBCP

Parents

Sign in to add mentor
Philip S. Low grad student 2007 Purdue
 (Real time, non-invasive, in vivo imaging of targeted drugs to solid tumors via a high affinity ligand: Implications to improving targeted -drug delivery.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Read GH, Bailleul J, Vlashi E, et al. (2022) Metabolic response to radiation therapy in cancer. Molecular Carcinogenesis. 61: 200-224
Bhat K, Saki M, Vlashi E, et al. (2020) The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proceedings of the National Academy of Sciences of the United States of America
Duhachek-Muggy S, Bhat K, Medina P, et al. (2019) Radiation Mitigation of the Intestinal Acute Radiation Injury in Mice by 1-[(4-Nitrophenyl)Sulfonyl]-4-Phenylpiperazine. Stem Cells Translational Medicine
Zhang L, Bailleul J, Yazal T, et al. (2019) PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation. Breast Cancer Research and Treatment
Jung SY, Malhotra P, Nguyen KC, et al. (2019) The KRAS-variant and its impact on normal breast epithelial cell biology. Cell Death and Differentiation
Bhat K, Duhachek-Muggy S, Ramanathan R, et al. (2019) 1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injury. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 132: 8-15
Bhat K, Sandler K, Duhachek-Muggy S, et al. (2019) Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Research : Bcr. 21: 17
Bailleul J, Yazal T, Sung D, et al. (2019) Abstract C59: NRF2 drives metabolic reprogramming in irradiated pancreatic cancer cells and promotes radioresistance Cancer Research. 79
Bailleul J, Yazal T, Sung D, et al. (2019) Irradiation Reprograms GBM Metabolism Towards an Antioxidant Profile That Drives Radiation Resistance International Journal of Radiation Oncology*Biology*Physics. 105: S165-S166
Zhang L, Bochkur Dratver M, Yazal T, et al. (2018) Mebendazole potentiates radiation therapy in triple-negative breast cancer. International Journal of Radiation Oncology, Biology, Physics
See more...